MS drug developer Kyverna Therapeutics files for $100M IPO
https://seekingalpha.com/news/4055843-ms-drug-developer-kyverna-therapeutics-files-for-100m-ipo?source=feed_sector_healthcare
Jan 17, 2024 - Kyverna Therapeutics (KYTX), which is developing therapies for autoimmune disorders such as lupus and multiple sclerosis, has filed for a proposed $100M IPO. Read more here.
0
MS Emerging Markets Debt Fund Review: Emerging Market Bonds Outlook 2024
https://seekingalpha.com/article/4664214-msd-emerging-market-bonds-outlook-2024?source=feed_tag_etf_portfolio_strategy
Jan 22, 2024 - MSD is a closed-ended fixed-income fund focused on emerging markets, aiming for high income and some capital appreciation. Click here to read my analysis.
0
Do Investors Have Too Much Money Out of the Market?
https://www.fool.com/investing/2024/01/28/do-investors-have-too-much-money-out-of-the-market/?source=iedfolrf0000001
Jan 28, 2024 - We've also got a look at two stocks worth watching: Globus Medical and RPM International.
0
Contineum Therapeutics Seeks $150 Million IPO For MS Treatments
https://seekingalpha.com/article/4679126-contineum-therapeutics-seeks-150-million-ipo-for-ms-treatments?source=feed_tag_ipo_analysis
Mar 19, 2024 - Contineum Therapeutics plans to raise $150 million through an IPO for developing advanced medical treatments, with strong institutional support and a key...
0
Clene stock rallies 52% post-market on MS drug data
https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare
Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
0
MS India Investment Fund declares $3.1357 dividend
https://seekingalpha.com/news/4043667-ms-india-investment-fund-declares-31357-dividend?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Dec 05, 2023 - MS India Investment Fund (IIF) declares total dividend of $3.1357/share, including STCG 0.2847, LTCG 2.851 dividend. Payable Jan. 12; for shareholders of record
0
Morgan Stanley (MS) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4663111-morgan-stanley-ms-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Jan 16, 2024 - Morgan Stanley (NYSE:NYSE:MS) Q4 2023 Earnings Conference Call January 16, 2024 8:30 AM ETCompany ParticipantsTed Pick - CEOSharon Yeshaya - CFOConference...
0
Bitcoin ETFs, the Gig Economy, and Robotic Surgery
https://www.fool.com/investing/2024/01/16/bitcoin-etfs-the-gig-economy-and-robotic-surgery/?source=iedfolrf0000001
Jan 16, 2024 - These investors have a lot to talk about. And Burford Capital CEO Chris Bogart drops in to talk about the world of legal financing, his company's competitive advantages, and a high-stakes case with Argentina.
0
This Electric Vehicle Stock Has 75% Upside, According to 1 Wall Street Analyst
https://www.fool.com/investing/2024/02/25/this-electric-vehicle-stock-has-78-upside-accordin/?source=iedfolrf0000001
Feb 25, 2024 - Investors continue to underestimate the company's potential, according to a team of pundits.
0
MS drug developer Contineum files for $150M IPO
https://seekingalpha.com/news/4081227-ms-drug-developer-contineum-files-for-150m-ipo?source=feed_sector_healthcare
Mar 19, 2024 - Contineum Therapeutics (CTNM), which is developing therapies for multiple sclerosis and idiopathic pulmonary fibrosis, has filed for a proposed $150M IPO. Read more here.
0
Page 1>